Suppr超能文献

用于消除格雷夫斯病甲亢的最佳碘-131剂量。

Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.

作者信息

Nordyke R A, Gilbert F I

机构信息

Department of Nuclear Medicine, Straub Clinic & Hospital, Honolulu, Hawaii 96813.

出版信息

J Nucl Med. 1991 Mar;32(3):411-6.

PMID:2005449
Abstract

Since hypothyroidism is commonplace after treatment of Graves' disease with radioiodine, the goal should be cure of hyperthyroidism rather than avoidance of hypothyroidism. To find the optimal dose to accomplish cure, we treated 605 patients with stepwise increasing doses of 3, 4, 5, 6, 8, and 10 mCi, analyzing the relationship of dose, age, sex, gland weight, and thyroidal uptake to cure. Estimates of cure at doses above 10 mCi were made from the literature. Cure was directly related to dose between 5 and 10 mCi. There was no significant relationship between cure and age (chi-square, p = 0.74), sex (chi-square, p = 0.12), and 24-hr uptake if over 30% (chi-square for slope, p greater than 0.10). Cure and gland weight had an inverse relationship (chi-square for slope, 0.01 less than p less than 0.02). We concluded that the optimal 131I dose for curing hyperthyroidism is approximated by starting with 10 mCi and increasing it for unusually large glands or for special patient circumstances.

摘要

由于用放射性碘治疗格雷夫斯病后甲状腺功能减退很常见,所以目标应该是治愈甲状腺功能亢进,而不是避免甲状腺功能减退。为了找到实现治愈的最佳剂量,我们用3、4、5、6、8和10毫居里逐步增加的剂量治疗了605名患者,分析剂量、年龄、性别、腺体重量和甲状腺摄取与治愈之间的关系。10毫居里以上剂量的治愈率估计来自文献。5至10毫居里之间,治愈率与剂量直接相关。治愈率与年龄(卡方检验,p = 0.74)、性别(卡方检验,p = 0.12)以及24小时摄取率(如果超过30%)之间无显著关系(斜率卡方检验,p大于0.10)。治愈率与腺体重量呈反比关系(斜率卡方检验,0.01小于p小于0.02)。我们得出结论,治愈甲状腺功能亢进的最佳131I剂量大约是从10毫居里开始,如果腺体异常大或有特殊患者情况则增加剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验